A NIS Evaluating Injectable Treatments in Patients With Relapsing Multiple Sclerosis
Condition(s):Relapsing Multiple SclerosisLast Updated:March 21, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Relapsing Multiple SclerosisLast Updated:March 21, 2024Recruiting
Condition(s):Relapsing Multiple SclerosisLast Updated:February 6, 2024Active, not recruiting
Condition(s):Relapsing Multiple SclerosisLast Updated:October 3, 2023Recruiting
Condition(s):Relapsing Multiple SclerosisLast Updated:December 9, 2021Terminated
Condition(s):Relapsing Multiple SclerosisLast Updated:March 8, 2024Completed
Condition(s):Relapsing Multiple SclerosisLast Updated:February 6, 2024Recruiting
Condition(s):Relapsing Multiple SclerosisLast Updated:July 17, 2023Recruiting
Condition(s):Relapsing Multiple SclerosisLast Updated:November 18, 2023Recruiting
Condition(s):Relapsing Multiple SclerosisLast Updated:March 4, 2024Completed
Condition(s):Relapsing Multiple SclerosisLast Updated:October 7, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.